May 30, 2018
New products formulated from derivations of hyaluronic acid are soaring in demand among dry eye syndrome patients internationally, according to Future Market Insights, whose latest study on the global dry eye syndrome treatment market predicts that developing products with hyaluronic acid formulations “will be observed lucrative for the market’s overall expansion.”
Growing preference of consumers toward preservative-free, single-dose remedies on dry eye syndrome is expected to stimulate the market’s growth, Future Market Insights reports: “The market is also expected to witness promising support from governments and private organizations through awareness campaigns and other initiatives in the field of ophthalmic care.”
Toward the end of 2027, the global market for dry eye syndrome treatment is predicted to expand at a 6.4 percent compound annual growth rate (CAGR), roughly doubling the 2017 value estimations by reaching US$ 6,609.3 Mn.
